The US Food and Drug Administration (FDA) has issued notices inviting subject-matter experts and consumer representatives to volunteer for its advisory committees. The move comes after the role of FDA ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
In Focus: US Members of Congress push back on plan to create a commission of political appointees to review NIH grants (STAT) Psychedelic REMS framework must start with data standardization, ...
A panel of regulators convened at the 2026 RAPS Convergence to discuss several initiatives underway in Europe to help ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
This week, a Senate committee scheduled a hearing for President Trump’s nominee to lead FDA, new reporting sheds light on the ...
Commissioner Robert Califf was a medical student in the mid-1970s, he had an opportunity to work with his mentor on one of ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing. In Foc ...
CHARLOTTE, NC — Whether the US Food and Drug Administration (FDA) will accept clinical evidence from outside the United States (OUS) depends on if the investigations followed good clinical practice ...
CHARLOTTE, NC — A panel of experts representing the European Commission, industry, and notified bodies reviewed the state ...
Officials from the European Commission and European Medicines Agency (EMA) touted key reforms presented in the proposal to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results